Invention Grant
- Patent Title: Modulation of T cells with bispecific antibodies and FC fusions
-
Application No.: US15063441Application Date: 2016-03-07
-
Publication No.: US10227411B2Publication Date: 2019-03-12
- Inventor: Matthew Bernett , Seung Chu , Dilki Wickramarachichi , John Desjarlais
- Applicant: Xencor, Inc.
- Applicant Address: US CA Monrovia
- Assignee: Xencor, Inc.
- Current Assignee: Xencor, Inc.
- Current Assignee Address: US CA Monrovia
- Agency: Morgan, Lewis & Bockius, LLP
- Agent Robin M. Silva; Louis T. Nguyen
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/28 ; A61K39/00
Abstract:
The present invention relates to methods and compositions for modulating T cells. The modulation includes suppressing or inducing regulatory T cells or cytotoxic T cells.
Public/Granted literature
- US20170037131A1 MODULATION OF T CELLS WITH BISPECIFIC ANTIBODIES AND FC FUSIONS Public/Granted day:2017-02-09
Information query
